GlobeNewswire: Inotiv, Inc. Contains the last 10 of 134 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T11:27:24ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/07/2825561/0/en/Inotiv-Reports-First-Quarter-Financial-Results-for-Fiscal-2024-and-Provides-Business-Update.html?f=22&fvtc=4&fvtv=47850Inotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business Update2024-02-07T21:05:00Z<![CDATA[- First quarter fiscal 2024 revenue up 10.3% to $135.5 million]]>https://www.globenewswire.com/news-release/2024/01/29/2819424/0/en/Inotiv-Inc-to-Report-Fiscal-2024-First-Quarter-Financial-Results-and-Host-Conference-Call-on-Wednesday-February-7-2024.html?f=22&fvtc=4&fvtv=47850Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 20242024-01-29T21:05:00Z<![CDATA[WEST LAFAYETTE, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2024 first quarter ended December 31, 2023, on Wednesday, February 7, 2024, after the close of the stock market. The Company will host a conference call that same day at 4:30 p.m. Eastern Time to discuss the results.]]>https://www.globenewswire.com/news-release/2023/12/11/2794268/0/en/Inotiv-Reports-Fourth-Quarter-and-Full-Year-Financial-Results-for-Fiscal-2023-and-Provides-Business-Update.html?f=22&fvtc=4&fvtv=47850Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2023 and Provides Business Update 2023-12-11T21:05:00Z<![CDATA[— Fiscal year 2023 revenue up 4.5% to $572.4 million, achieving full year revised guidance— Achievements in the past fiscal year to expand DSA capacity, develop new services and reduce outsourcing expected to drive continued growth of fiscal 2024 DSA revenues— Anticipate achieving the balance of expected expense reductions in fiscal 2024— Conference call begins today at 4:30 pm ET]]>https://www.globenewswire.com/news-release/2023/12/06/2792120/0/en/Inotiv-Inc-Announces-Plan-to-Insource-North-American-Transportation-Operations.html?f=22&fvtc=4&fvtv=47850Inotiv, Inc. Announces Plan to Insource North American Transportation Operations2023-12-06T21:30:00Z<![CDATA[WEST LAFAYETTE, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that the Company will be partnering with Vanguard Supply Chain Solutions LLC, the Company’s current provider of transportation services, to enable the in-house integration of Inotiv’s North American transportation operations.]]>https://www.globenewswire.com/news-release/2023/11/27/2786522/0/en/Inotiv-Inc-to-Report-Fiscal-2023-Fourth-Quarter-and-Full-Year-Results-and-Host-Conference-Call-on-Monday-December-11-2023.html?f=22&fvtc=4&fvtv=47850Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 20232023-11-27T21:05:00Z<![CDATA[WEST LAFAYETTE, Ind., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that it will issue its financial results for the fiscal 2023 fourth quarter and full year ended September 30, 2023, on Monday, December 11, 2023, after the close of the stock market. The Company will host a conference call that same day at 4:30 p.m. Eastern Time to discuss the results.]]>https://www.globenewswire.com/news-release/2023/11/13/2779445/0/en/Inotiv-Provides-Business-Updates-and-Upcoming-Investor-Conferences-Update.html?f=22&fvtc=4&fvtv=47850Inotiv Provides Business Updates and Upcoming Investor Conferences Update2023-11-13T21:05:00Z<![CDATA[WEST LAFAYETTE, Ind., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today provides business updates related to Inotiv’s operations and an update regarding its participation in upcoming investor conferences.]]>https://www.globenewswire.com/news-release/2023/11/08/2776113/0/en/Inotiv-Ranked-Number-127-Fastest-Growing-Company-in-North-America-on-the-2023-Deloitte-Technology-Fast-500.html?f=22&fvtc=4&fvtv=47850Inotiv Ranked Number 127 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™2023-11-08T12:30:00Z<![CDATA[Attributes 1156% Revenue Growth to Adding Strategic Capacity, Key Integration Initiatives, Optimization of Infrastructure, and Right-Sizing its Global Footprint Attributes 1156% Revenue Growth to Adding Strategic Capacity, Key Integration Initiatives, Optimization of Infrastructure, and Right-Sizing its Global Footprint]]>https://www.globenewswire.com/news-release/2023/11/01/2771067/0/en/Inotiv-Inc-to-Participate-in-Upcoming-Investor-Conferences.html?f=22&fvtc=4&fvtv=47850Inotiv, Inc. to Participate in Upcoming Investor Conferences2023-11-01T12:00:00Z<![CDATA[WEST LAFAYETTE, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced that Robert Leasure Jr., President and Chief Executive Officer, and Beth Taylor, Chief Financial Officer, will participate in multiple upcoming investor conferences throughout November 2023.]]>https://www.globenewswire.com/news-release/2023/10/16/2760610/0/en/Inotiv-Inc-Announces-Changes-to-its-Board-Composition.html?f=22&fvtc=4&fvtv=47850Inotiv, Inc. Announces Changes to its Board Composition2023-10-16T12:00:00Z<![CDATA[WEST LAFAYETTE, Ind., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization, today announced the appointment of Terry Coelho to its Board of Directors. Ms. Coelho is replacing Richard A. Johnson PhD, who is leaving the Board as part of the Board’s succession planning. Ms. Coelho was also appointed to serve as a member of the Compensation Committee and the Audit Committee, and as a member and the Chair of the Nominating/Corporate Governance Committee of the Board.]]>https://www.globenewswire.com/news-release/2023/08/29/2733954/0/en/Inotiv-Announces-the-Sale-of-its-Israeli-Businesses-to-Harlan-Holdings-Ltd.html?f=22&fvtc=4&fvtv=47850Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.2023-08-29T22:47:13Z<![CDATA[WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and services, today announced the completion of the sale of its businesses in Israel. The sale complements Inotiv’s site optimization plan for the Research Models and Services segment of the business.]]>